0001213900-22-008936.txt : 20220223 0001213900-22-008936.hdr.sgml : 20220223 20220223161044 ACCESSION NUMBER: 0001213900-22-008936 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220218 FILED AS OF DATE: 20220223 DATE AS OF CHANGE: 20220223 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mounts Phoebe CENTRAL INDEX KEY: 0001777330 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34673 FILM NUMBER: 22663667 MAIL ADDRESS: STREET 1: 400 CONNELL DRIVE STREET 2: SUITE 5000 CITY: BERKELEY HEIGHTS STATE: NJ ZIP: 07822 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CorMedix Inc. CENTRAL INDEX KEY: 0001410098 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300 CONNELL DRIVE STREET 2: SUITE 4200 CITY: BERKELEY HEIGHTS STATE: NJ ZIP: 07922 BUSINESS PHONE: 908-517-9500 MAIL ADDRESS: STREET 1: 300 CONNELL DRIVE STREET 2: SUITE 4200 CITY: BERKELEY HEIGHTS STATE: NJ ZIP: 07922 4 1 doc4.xml PRIMARY DOCUMENT X0306 4 2022-02-18 false 0001410098 CorMedix Inc. CRMD 0001777330 Mounts Phoebe C/O CORMEDIX INC. 300 CONNELL DRIVE, SUITE 4200 BERKELEY HEIGHTS NJ 07922 false true false false General Counsel Common Stock 7200.0000 D Stock Option (Right to Buy) 4.0300 2022-02-18 4 A false 140000.0000 0.0000 A 2032-02-18 Common Stock 140000.0000 140000.0000 D Stock Option (Right to Buy) 5.5600 2031-11-01 Common Stock 100000.0000 100000.0000 D Stock Option (Right to Buy) 8.3200 2031-01-11 Common Stock 140000.0000 140000.0000 D Stock Option (Right to Buy) 5.6300 2030-05-11 Common Stock 50000.0000 50000.0000 D Stock Option (Right to Buy) 4.0800 2030-05-11 Common Stock 50000.0000 50000.0000 D Stock Option (Right to Buy) 5.6300 2030-02-25 Common Stock 24764.0000 24764.0000 D Stock Option (Right to Buy) 7.9200 2029-05-01 Common Stock 70000.0000 70000.0000 D These options were granted on 11/1/2021. These options vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant. These options were granted on 1/11/2021. These options vest, subject to continued employment, as follows: 50% of the options vest over time, with 25% vested on the grant date and 25% vesting in equal thirds on the first, second and third anniversaries of the grant date; and 50% of the options vest upon the achievement of certain milestones. These options were granted on 05/11/2020. These options vest 1/4 on the date of grant, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant. These options were granted on 02/25/2020. These options vest 1/4 on the date of grant, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant. The options vest as follows: 42,000 vest in equal fourths on May 1 of each of 2020, 2021, 2022 and 2023 and 28,000 vest upon the achievement of designated milestones. These options were granted on 2/18/2022. These options vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant. The Issuer effected a 1-for-5 reverse stock split of its common stock on March 26, 2019. All share and per share exercise price amounts shown in this Form 4 have been adjusted to reflect the reverse stock split. /s/ Phoebe Mounts 2022-02-22